Brief: Anika Therapeutics Q2 Revenue USD 41.921 Million

Anika Therapeutics

08/08/2024 21:06

Aug 08 (Reuters) - Anika Therapeutics Q2 gross profit USD 27.365 million.
* Q2 income from operations USD 161 thousand
* Q2 pretax profit USD 756 thousand
* Q2 net income USD -88 thousand